Literature DB >> 21345358

Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.

Lei Zhang1, Xuefei Cai, Ke Chen, Zengchan Wang, Liying Wang, Min Ren, Ailong Huang, Hua Tang.   

Abstract

The hepatitis B virus (HBV) protein plays a major role in hepatocellular carcinoma (HCC) development. However, its contribution to tumor invasion and metastasis has not been established so far. HLJ1 was recently cloned and classified as a member of the heat shock protein 40 family (Hsp40/DnaJ) which is abundantly expressed in HBV-related tumors, might be involved in tumor progression. In this study, the role of HBV in activation of HLJ1 was investigated. In HepG2 cells with transit or stable expression of HBV, HLJ1 expression was activated by HBV. The activity assay of HLJ1 promoter revealed that HBV up-regulated HLJ1 expression through the transcription factor YY1 sites within the HLJ1 promoter. YY1 expression was significantly up-regulated by HBV in a concentration-dependent manner. Knockdown of YY1 expression could partially reduce the HBV-induced HLJ1 activation which indicated that YY1 would be involved in HBV-induced HLJ1 expression. In conclusion, our data showed that HBV could promote HLJ1 expression by up-regulating the transcription factor YY1, and this provided a new insight of the mechanism of HBV induction in tumor metastasis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345358     DOI: 10.1016/j.virusres.2011.02.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

Review 1.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

2.  Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.

Authors:  Shengjie Zhang; Tingting Jiang; Lifeng Feng; Jie Sun; Haiqi Lu; Qinchuan Wang; Min Pan; Dongsheng Huang; Xian Wang; Linbo Wang; Hongchuan Jin
Journal:  J Mol Med (Berl)       Date:  2012-03-06       Impact factor: 4.599

Review 3.  Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.

Authors:  Sandy Leung-Kuen Au; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2013-04-26       Impact factor: 4.592

Review 4.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 5.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.

Authors:  Yong Liu; Jie Zhou; Cuiwei Zhang; Wenguang Fu; Xiuli Xiao; Sibei Ruan; Yuan Zhang; Xia Luo; Mingxi Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

7.  Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes.

Authors:  Liyuan Wang; Yang Sun; Xiaojia Song; Zehua Wang; Yankun Zhang; Ying Zhao; Xueqi Peng; Xiaodong Zhang; Chunyang Li; Chengjiang Gao; Nailin Li; Lifen Gao; Xiaohong Liang; Zhuanchang Wu; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2021-07-12       Impact factor: 22.096

8.  Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells.

Authors:  Kai Li; Shijia Ding; Ke Chen; Dongdong Qin; Jialin Qu; Sen Wang; Yanrui Sheng; Chengcheng Zou; Limin Chen; Hua Tang
Journal:  Hepat Mon       Date:  2013-05-27       Impact factor: 0.660

Review 9.  Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression.

Authors:  Vaishali Kashyap; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2014-03

Review 10.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.